A Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in Malaysia

A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and Safety

NCT01712178 ·Status: COMPLETED ·Phase: PHASE2

Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases

NCT03339089 ·Status: COMPLETED

Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical Practice

NCT01078090 ·Status: COMPLETED

Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment)

NCT01346488 ·Status: COMPLETED

Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab

NCT02627924 ·Status: COMPLETED

Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate

NCT00235859 ·Status: COMPLETED ·Phase: PHASE3

Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

NCT00235872 ·Status: COMPLETED ·Phase: PHASE3

Quality of Life Study With Adalimumab in Rheumatoid Arthritis

NCT00234936 ·Status: COMPLETED ·Phase: PHASE3

Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium

NCT01845818 ·Status: COMPLETED

Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological Agents

NCT01783730 ·Status: COMPLETED

Study of Adalimumab in Patients With Axial Spondyloarthritis

NCT00939003 ·Status: COMPLETED ·Phase: PHASE3

Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab

NCT01273519 ·Status: COMPLETED

Observational Study to Explore the Effectiveness of Adalimumab Treatment in Conjunction With Utilization of a Patient Support Program (PSP)

NCT01383421 ·Status: COMPLETED

A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

NCT00647491 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Rheumatoid Arthritis Satisfaction Outcome Research

NCT03703817 ·Status: COMPLETED

Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing

NCT00647270 ·Status: COMPLETED ·Phase: PHASE3

The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthritis. A Pilot Study.

NCT01270087 ·Status: COMPLETED ·Phase: PHASE4

Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis

NCT00649545 ·Status: APPROVED_FOR_MARKETING

Pharmacokinetic and Safety Study With Adalimumab in Chinese Subjects With Mild Rheumatoid Arthritis

NCT00650156 ·Status: COMPLETED ·Phase: PHASE1

Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab

NCT00650390 ·Status: APPROVED_FOR_MARKETING

Investigation of Immunological and Pharmacological Factors for Response to Adalimumab in Rheumatoid Arthritis

NCT03110094 ·Status: COMPLETED ·Phase: NA

Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China

NCT02668640 ·Status: COMPLETED

Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis

NCT01078571 ·Status: COMPLETED

Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

NCT00235833 ·Status: COMPLETED ·Phase: PHASE2

Post-marketing Observational Study in Subjects With Rheumatoid Arthritis

NCT00234884 ·Status: COMPLETED